Free Trial

MacroGenics (MGNX) Competitors

MacroGenics logo
$1.58 -0.01 (-0.63%)
Closing price 04:00 PM Eastern
Extended Trading
$1.58 +0.00 (+0.06%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MGNX vs. BNTC, AVIR, IVA, AARD, OCGN, GOSS, ALT, GLUE, RNAC, and TKNO

Should you be buying MacroGenics stock or one of its competitors? The main competitors of MacroGenics include Benitec Biopharma (BNTC), Atea Pharmaceuticals (AVIR), Inventiva (IVA), Aardvark Therapeutics (AARD), Ocugen (OCGN), Gossamer Bio (GOSS), Altimmune (ALT), Monte Rosa Therapeutics (GLUE), Cartesian Therapeutics (RNAC), and Alpha Teknova (TKNO). These companies are all part of the "pharmaceutical products" industry.

MacroGenics vs. Its Competitors

Benitec Biopharma (NASDAQ:BNTC) and MacroGenics (NASDAQ:MGNX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Benitec Biopharma has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500. Comparatively, MacroGenics has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500.

52.2% of Benitec Biopharma shares are held by institutional investors. Comparatively, 96.9% of MacroGenics shares are held by institutional investors. 1.3% of Benitec Biopharma shares are held by company insiders. Comparatively, 13.0% of MacroGenics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Benitec Biopharma has a net margin of 0.00% compared to MacroGenics' net margin of -36.23%. Benitec Biopharma's return on equity of -38.26% beat MacroGenics' return on equity.

Company Net Margins Return on Equity Return on Assets
Benitec BiopharmaN/A -38.26% -35.71%
MacroGenics -36.23%-59.84%-23.45%

Benitec Biopharma presently has a consensus price target of $23.83, indicating a potential upside of 72.83%. MacroGenics has a consensus price target of $5.71, indicating a potential upside of 261.66%. Given MacroGenics' higher probable upside, analysts clearly believe MacroGenics is more favorable than Benitec Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Benitec Biopharma
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
2 Strong Buy rating(s)
3.20
MacroGenics
0 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.40

In the previous week, Benitec Biopharma had 3 more articles in the media than MacroGenics. MarketBeat recorded 6 mentions for Benitec Biopharma and 3 mentions for MacroGenics. Benitec Biopharma's average media sentiment score of 0.36 beat MacroGenics' score of 0.34 indicating that Benitec Biopharma is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Benitec Biopharma
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
MacroGenics
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Benitec Biopharma has higher earnings, but lower revenue than MacroGenics. Benitec Biopharma is trading at a lower price-to-earnings ratio than MacroGenics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Benitec Biopharma$80K4,524.84-$21.75M-$1.51-9.13
MacroGenics$149.96M0.66-$66.97M-$0.89-1.78

Summary

Benitec Biopharma beats MacroGenics on 9 of the 17 factors compared between the two stocks.

Get MacroGenics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGNX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MGNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGNX vs. The Competition

MetricMacroGenicsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$100.31M$10.57B$5.56B$9.04B
Dividend YieldN/A2.08%5.25%4.03%
P/E Ratio-1.7816.5627.1820.14
Price / Sales0.6630.26440.78137.14
Price / CashN/A22.8437.5058.41
Price / Book0.853.758.085.60
Net Income-$66.97M$235.43M$3.16B$248.43M
7 Day Performance9.72%3.78%3.77%5.15%
1 Month Performance-11.24%3.95%3.90%7.62%
1 Year Performance-63.00%-9.49%34.22%21.56%

MacroGenics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGNX
MacroGenics
4.1369 of 5 stars
$1.58
-0.6%
$5.71
+261.7%
-62.8%$100.31M$149.96M-1.78430
BNTC
Benitec Biopharma
2.1687 of 5 stars
$11.70
+3.1%
$23.83
+103.7%
+50.1%$297.94M$80K-7.7520News Coverage
Analyst Forecast
High Trading Volume
AVIR
Atea Pharmaceuticals
3.1438 of 5 stars
$3.60
+4.3%
$6.00
+66.7%
+17.9%$295.25MN/A-2.1870News Coverage
High Trading Volume
IVA
Inventiva
3.2604 of 5 stars
$3.19
+4.6%
$10.40
+226.0%
+28.1%$291.77M$9.95M0.00100News Coverage
AARD
Aardvark Therapeutics
N/A$13.52
+1.0%
$33.00
+144.1%
N/A$290.51MN/A0.0018
OCGN
Ocugen
1.0008 of 5 stars
$0.97
-1.4%
$6.00
+518.3%
-37.4%$287.39M$4.05M-5.1180High Trading Volume
GOSS
Gossamer Bio
3.7676 of 5 stars
$1.23
-1.6%
$7.33
+496.2%
+13.3%$284.13M$114.70M-5.35180
ALT
Altimmune
2.3183 of 5 stars
$3.87
+10.6%
$19.00
+391.0%
-31.3%$283.87M$20K-3.0750News Coverage
Analyst Forecast
Gap Down
High Trading Volume
GLUE
Monte Rosa Therapeutics
1.3618 of 5 stars
$4.51
-2.0%
$15.33
+240.0%
+33.6%$282.95M$75.62M56.3890Positive News
RNAC
Cartesian Therapeutics
2.016 of 5 stars
$10.39
-2.7%
$41.25
+297.0%
-17.9%$277.19M$38.91M-0.2064News Coverage
Analyst Forecast
TKNO
Alpha Teknova
3.0684 of 5 stars
$4.91
-3.9%
$8.50
+73.1%
+329.3%$273.08M$37.74M-10.23240News Coverage

Related Companies and Tools


This page (NASDAQ:MGNX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners